Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12
Published July 29, 2020 · Recall initiated: June 17, 2020
Summary
FDA records drug Class III recall D-1392-2020, published July 29, 2020 and initiated June 17, 2020. Recalling firm: HF Acquisition Co. LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 6122639, Exp. Date 08/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
What to do
Voluntary: Firm initiated · Letter
Get an email if FAMOTIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FAMOTIDINE
- Manufacturer
- HF Acquisition Co. LLC
- Distributor
- The vials were distributed to one consignee located in CT.
- UPC
- 0363323739119
- Lot
- Lot #: 6122639, Exp. Date 08/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFamotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only,September 9, 2026
- FDAFamotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDCDecember 3, 2025
- FDAFamotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc.,July 26, 2023
- FDAFamotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279March 10, 2021
- FDACefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: LupinJuly 29, 2020
- FDADRW-0739-02: Gen 2 Posterior Chairside Splint LRUL (lower right-upper left) - Product Usage: intended toJuly 22, 2020
Questions about this recall
Was Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12 recalled?
Yes. FDA published recall D-1392-2020 on July 29, 2020. Reported hazard: TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FAMOTIDINE. UPC: 0363323739119.